OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Clinical trials for OLIGOMETASTATIC PROSTATE CANCER (OMPC) explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CANCER (OMPC) trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CANCER (OMPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental DNA vaccine aims to train immune system against prostate cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests whether an experimental DNA vaccine (pTVG-HP) combined with the immunotherapy drug nivolumab and targeted radiation can help the immune system attack prostate cancer that has returned in a few spots. The study involves 14 men whose cancer has come bac…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
Radioactive therapy aims to stall prostate cancer spread without hormone drugs
Disease control Recruiting nowThis phase 3 trial tests a radioactive drug called lutetium-177 vipivotide tetraxetan in 450 men whose prostate cancer has returned and spread to a few spots after initial treatment. The drug targets a protein on cancer cells and delivers radiation directly to them. The goal is t…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can we safely zap more cancer spots? new study pushes radiation limits
Knowledge-focused Recruiting nowThis study is for people with advanced prostate cancer that has spread to bones or lymph nodes and is no longer responding to standard treatments. Researchers want to find the largest total volume of cancer spots that can be safely treated with a precise type of radiation called …
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC